Treelife Resources

If your SaaS platform bills an Indian credit card, UPI handle, or wallet directly, without routing the sale through an Indian reseller or app store, Indian GST law treats you as a supplier operating inside India, whether or not you have a rupee bank account, an office, or a single…

A medical device cannot be legally manufactured, sold, distributed or imported into India without the correct authorisation from the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority under the Directorate General of Health Services, Ministry of Health and Family Welfare. The Medical Devices Rules 2017, framed under the…

Any business in India that exchanges, transfers, safe-keeps, or helps issue virtual digital assets is a reporting entity under the Prevention of Money Laundering Act, 2002, whether it is incorporated in Bengaluru or Dubai. This obligation was created by a single notification from the Ministry of Finance in March 2023…

A manufacturing entity in India needs four things to run legally: a valid corporate structure, land with the right zoning, a factory licence, and environmental consent from the state pollution control board. What governs that factory licence changed materially on 21 November 2025, when the Occupational Safety, Health and Working…

Every brand that ships a physical product wrapped, cushioned or sealed in plastic is a Producer, Importer or Brand Owner (PIBO) under the Plastic Waste Management Rules, 2016, and carries a registration obligation with the Central Pollution Control Board (CPCB). This is not a rule aimed only at large manufacturers….

If your SaaS platform bills an Indian credit card, UPI handle, or wallet directly, without routing the sale through an Indian reseller or app store, Indian GST law treats you as a supplier operating inside India, whether or not you have a rupee bank account, an office, or a single…

A medical device cannot be legally manufactured, sold, distributed or imported into India without the correct authorisation from the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority under the Directorate General of Health Services, Ministry of Health and Family Welfare. The Medical Devices Rules 2017, framed under the…

A manufacturing entity in India needs four things to run legally: a valid corporate structure, land with the right zoning, a factory licence, and environmental consent from the state pollution control board. What governs that factory licence changed materially on 21 November 2025, when the Occupational Safety, Health and Working…

A foreign parent setting up a software delivery centre or Global Capability Centre (GCC) in India will hit the STPI question within the first month of incorporation, usually when the finance team asks how import duty on laptops and servers is going to be handled. STPI registration, run under the…

Setting up a semiconductor or electronics manufacturing unit in India runs across four tracks that have to be sequenced correctly: choosing the right entity structure, filing under the scheme that actually matches your facility type, clearing state land and environmental approvals, and carrying a central government application through appraisal to…

SEBI issued its updated Master Circular for Alternative Investment Funds (AIFs) on 03 June 2026, consolidating every circular, clarification, and regulatory change issued under the SEBI (Alternative Investment Funds) Regulations, 2012 up to 31 May 2026. The document runs 153 pages across 25 chapters and supersedes the previous Master Circular…

The Reserve Bank of India held its benchmark repo rate steady at 5.25% at the June 2026 Monetary Policy Committee meeting, unanimously, under Governor Sanjay Malhotra. This is the third meeting in a row that the rate has stayed put, following a run of 150 basis point cuts between February…

India’s Cabinet approved an amendment to Press Note 3 (PN3) of 2020 in March 2026, and it is generating significant attention across the investment and startup community. Headlines have rushed to label it a sweeping FDI liberalisation. The reality is considerably more targeted. This report breaks down exactly what changed,…

The Securities and Exchange Board of India (SEBI) recently announced a major overhaul to the regulatory framework for Angel Funds under the Alternative Investment Funds (AIF) Regulations, 2012. This new framework, introduced in 2025, aims to enhance transparency, improve operational clarity, and encourage investor participation. In this article, we’ll explore…

In a significant move to invigorate India’s startup ecosystem, the Securities and Exchange Board of India (SEBI), during its board meeting on June 19, 2025, approved substantial changes to the Angel Fund Framework. These revisions are designed to unlock more capital for early-stage companies while simultaneously ensuring enhanced investor suitability…